These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1405247)

  • 1. [Effects of calcium antagonists on carbohydrate and lipid metabolism].
    Preobrazhenskiĭ DV; Fomichev VI; Afanas'ev AIa
    Kardiologiia; 1992 Apr; 32(4):84-9. PubMed ID: 1405247
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effect of ursodeoxycholic acid and calcium antagonists on the binding, uptake and degradation of LDL in isolated hamster hepatocytes.
    Bouscarel B; Ceryak S; Fromm H
    Biochim Biophys Acta; 1996 Jun; 1301(3):230-6. PubMed ID: 8664333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Ca2+ blocking agents on the metabolism of low density lipoproteins in human skin fibroblasts.
    Ranganathan S; Harmony JA; Jackson RJ
    Biochem Biophys Res Commun; 1982 Jul; 107(1):217-24. PubMed ID: 7126204
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormalities of carbohydrate and lipid metabolism in experimentally induced acute uremia.
    Nitzan M
    Nutr Metab; 1973; 15(3):187-91. PubMed ID: 4352215
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium channel blocking agents.
    Ewy GA
    Med Times; 1981 Aug; 109(8):36-8. PubMed ID: 6268924
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcium antagonists increase the amount of mRNA for the low-density lipoprotein receptor in skin fibroblasts.
    Eckardt H; Filipovic I
    Artery; 1991; 18(4):168-83. PubMed ID: 1651691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDL receptor gene expression in human mesangial cells under the influence of calcium channel blockers.
    Ruan XZ; Varghese Z; Fernando R; Powas SH; Moorhead JF
    Clin Nephrol; 1999 May; 51(5):263-71. PubMed ID: 10363626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calcium channel blocker LAS 30538, unlike nifedipine, verapamil, diltiazem or flunarizine, potently inhibits insulin secretion in-vivo in rats and dogs.
    Gristwood RW; Furman BL; Llenas J; Jauregui J; Berga P
    J Pharm Pharmacol; 1992 Oct; 44(10):851-5. PubMed ID: 1360513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P; Kannan NK
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticholinesterase effect of calcium channel blockers: diltiazem, verapamil, and nifedipine].
    Ivanov IuIa
    Dokl Akad Nauk; 1998 Mar; 359(3):413-4. PubMed ID: 9608914
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium antagonists for acute ischemic heart disease.
    Winniford MD; Willerson JT; Hillis LD
    Am J Cardiol; 1985 Jan; 55(3):116B-124B. PubMed ID: 3881904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium antagonists. Properties and current indications].
    Amoroso A; Lanciotti G; Mammarella A
    Recenti Prog Med; 1984 Apr; 75(4):353-60. PubMed ID: 6374795
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myocardial cellular mechanism of action of calcium antagonists].
    Ferrari R; Boffa GM; Ciampalini G; Ceconi C
    Cardiologia; 1985 Feb; 30(2):77-89. PubMed ID: 3905004
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
    Krone W; Müller-Wieland D; Nägele H; Behnke B; Greten H
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S199-202. PubMed ID: 2455133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diltiazem hydrochloride on serum lipids: comparison with beta-blockers.
    Wada S; Nakayama M; Masaki K
    Clin Ther; 1982; 5(2):163-73. PubMed ID: 6130841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antihypertensive therapy on glucose tolerance: focus on calcium antagonists.
    Hedner T; Samuelsson O; Lindholm L
    J Intern Med Suppl; 1991; 735():101-11. PubMed ID: 2043219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
    Romics L; Karádi I; Rozenberczki M; Kammerer L
    Acta Med Acad Sci Hung; 1982; 39(3-4):117-23. PubMed ID: 6764327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of the plasma lipoproteins.
    Lewis B
    Sci Basis Med Annu Rev; 1972; ():118-44. PubMed ID: 4344060
    [No Abstract]   [Full Text] [Related]  

  • 19. Sexual dimorphism in the metabolic response to the calcium channel antagonists, diltiazem and clentiazem, by hyperlipidemic JCR:LA-cp rats.
    Russell JC; Graham SE; Stewart B; Dolphin PJ
    Biochim Biophys Acta; 1995 Sep; 1258(2):199-205. PubMed ID: 7548184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [METABOLIC DISORDERS IN OBESITY].
    HORNET NN; FARCHI A; RUSS M; NUTU J
    Med Interna (Bucur); 1964 Sep; 16():1079-90. PubMed ID: 14223021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.